Denis E. Boycov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Denis E. Boycov has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- German L. Perlovich
G.A. Krestov Institute of Solution Chemistry of the Russian Academy of Sciences, 1 Akademicheskaya St., 153045 Ivanovo, Russia
7 shared publications - Alex N. Manin
G.A. Krestov Institute of Solution Chemistry of the Russian Academy of Sciences, 1 Akademicheskaya St., Ivanovo, 153045, Russian Federation
6 shared publications - Andrei V. Churakov
N.S. Kurnakov Institute of General and Inorganic Chemistry RAS Moscow Russia
5 shared publications - Ksenia V. Drozd
G.A. Krestov Institute of Solution Chemistry of the Russian Academy of Sciences, 1 Akademicheskaya St., Ivanovo 153045, Russian Federation
5 shared publications - Alexander P. Voronin
G.A. Krestov Institute of Solution Chemistry of the Russian Academy of Sciences, 1 Akademicheskaya St., 153045 Ivanovo, Russia
2 shared publications - Anna G. Ramazanova
G.A. Krestov Institute of Solution Chemistry of the Russian Academy of Sciences, 1 Akademicheskaya St., 153045 Ivanovo, Russia
1 shared publication
Latest Publications
- Open Access
- 3 November 2026
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (11) , 1422
Pharmaceutical Salts vs. Ionic Cocrystals: A Combined Structural and Solubility Study of Fluoxetine Multicomponent Crystals
Background/Objectives: The present work constitutes the comparative study of solubility and dissolution parameters of pharmaceutical salts and ionic cocrystals using the ternary system (fluoxetine:hydrochloric acid:fumaric acid) as an example. Methods: A multi-stage synthesis based on extraction of fluoxetine (FXT) free base into the diethyl ether layer was used to isolate two stable fumaric acid (FumAc) salts with (1:1) and (2:1) stoichiometry and a metastable polymorph of the (1:1) salt. The solvent-dependent solubility of FXT∙HCl, [FXT+FumAc] (1:1) salt and [FXT∙HCl+FumAc] (2:1) ionic cocrystal was rationalized in terms of acid–base equilibria, common ion effect, activity coefficients and surfactant-like activity of FXT supported by crystal packing analysis. Different kinetic models were applied to fit the experimental dissolution profiles in blank and supplemented biorelevant FaSSGF and FaSSIF media. Results: The crystal structure of fluoxetine hydrogen fumarate was found to feature the robust layered packing involving 2D hydrogen-bonded sheets separated by FXTH+ bilayers. The highest solubility advantage with respect to commercial FXT∙HCl in acidic media (4.8 times) was confirmed for [FXT+FumAc] (1:1) in pH 1.2 buffer solution, while the [FXT∙HCl+FumAc] (2:1) ionic cocrystal demonstrates the highest solubility (1.9 times) in blank FaSSIF medium (pH 6.5). The dissolution kinetic of studied solid forms was best modeled by zero-order and Korsmeyer–Peppas models. Conclusions: The solubility and dissolution rate were established to be inversely dependent on the solid form stability in specific media. The ionic cocrystal was observed to be the only solid form to demonstrate improved dissolution rate in complemented FaSSGF due to the un-ionized state of fumaric acid resulting in formation of mixed micelles with solubilizers. The [FXT+FumAc] (1:1) salt and the [FXT∙HCl+FumAc] ionic cocrystal can be recommended as soluble solid forms of fluoxetine, respectively, for gastro-soluble and enteric-coated formulations.
- 3 November 2026
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (11) , 1422
Open AccessPharmaceutical Salts vs. Ionic Cocrystals: A Combined Structural and Solubility Study of Fluoxetine Multicomponent Crystals
Background/Objectives: The present work constitutes the comparative study of solubility and dissolution parameters of pharmaceutical salts and ionic cocrystals using the ternary system (fluoxetine:hydrochloric acid:fumaric acid) as an example. Methods: A multi-stage synthesis based on extraction of fluoxetine (FXT) free base into the diethyl ether layer was used to isolate two stable fumaric acid (FumAc) salts with (1:1) and (2:1) stoichiometry and a metastable polymorph of the (1:1) salt. The solvent-dependent solubility of FXT∙HCl, [FXT+FumAc] (1:1) salt and [FXT∙HCl+FumAc] (2:1) ionic cocrystal was rationalized in terms of acid–base equilibria, common ion effect, activity coefficients and surfactant-like activity of FXT supported by crystal packing analysis. Different kinetic models were applied to fit the experimental dissolution profiles in blank and supplemented biorelevant FaSSGF and FaSSIF media. Results: The crystal structure of fluoxetine hydrogen fumarate was found to feature the robust layered packing involving 2D hydrogen-bonded sheets separated by FXTH+ bilayers. The highest solubility advantage with respect to commercial FXT∙HCl in acidic media (4.8 times) was confirmed for [FXT+FumAc] (1:1) in pH 1.2 buffer solution, while the [FXT∙HCl+FumAc] (2:1) ionic cocrystal demonstrates the highest solubility (1.9 times) in blank FaSSIF medium (pH 6.5). The dissolution kinetic of studied solid forms was best modeled by zero-order and Korsmeyer–Peppas models. Conclusions: The solubility and dissolution rate were established to be inversely dependent on the solid form stability in specific media. The ionic cocrystal was observed to be the only solid form to demonstrate improved dissolution rate in complemented FaSSGF due to the un-ionized state of fumaric acid resulting in formation of mixed micelles with solubilizers. The [FXT+FumAc] (1:1) salt and the [FXT∙HCl+FumAc] ionic cocrystal can be recommended as soluble solid forms of fluoxetine, respectively, for gastro-soluble and enteric-coated formulations.
- 23 June 2026
- Published by Royal Society of Chemistry (RSC) in CrystEngComm
- Vol. 28 (30) , 4410-4420
Stoichiomorphic transition by sublimation: a case study of 4-aminobenzoic acid and isonicotinamide cocrystals
This study investigates the thermal stability and gas-phase synthesis of the [PABA + iNAM] (1 : 1) and (2 : 1) cocrystals, including the first report of the 1 : 1 crystal structure.
- 23 June 2026
- Published by Royal Society of Chemistry (RSC) in CrystEngComm
- Vol. 28 (30) , 4410-4420
Stoichiomorphic transition by sublimation: a case study of 4-aminobenzoic acid and isonicotinamide cocrystals
This study investigates the thermal stability and gas-phase synthesis of the [PABA + iNAM] (1 : 1) and (2 : 1) cocrystals, including the first report of the 1 : 1 crystal structure.
- Open Access
- 21 May 2025
- Published by MDPI AG in Pharmaceutics
- Vol. 17 (5) , 678
Novel Drug–Drug Cocrystalline Forms of Carbamazepine with Sulfacetamide: Preparation, Characterization, and In Vitro/In Vivo Performance Evaluation
Objectives: Drug–drug cocrystallization represents a promising approach for the development of novel combination drugs with improved physicochemical and biopharmaceutical properties. The aim of the present research is to prepare novel drug-drug cocrystalline forms of antiepileptic drug carbamazepine (CBZ) with sulfacetamide (SCTM). Methods: The novel CBZ cocrystal methanol solvate and cocrystal hydrate were prepared via solvent evaporation technique and characterized by single crystal X-ray diffraction, differential scanning calorimetry and thermogravimetric analysis. Results: Single-crystal X-ray diffraction and thermal analysis revealed that the multicomponent solids are isostructural, wherein the solvent molecule does not play a structure-forming role. To optimize the synthesis of [CBZ+SCTM+H2O] (1:1:0.7), the binary and ternary phase diagrams were constructed in acetonitrile at 25 °C. A thorough investigation of the cocrystal hydrate behavior in aqueous solution showed that the pH of the dissolution medium exerted a significant effect on the stability and solubility of [CBZ+SCTM+H2O] (1:1:0.7). According to the dissolution and diffusion experiments in a buffer solution pH 6.5, the cocrystal hydrate characterized an enhanced dissolution rate and flux of CBZ. Pharmacokinetic studies in rabbits showed that the novel cocrystal hydrate exhibited a comparable bioavailability to the parent CBZ. Conclusions: Overall, this work reports the preparation of a novel CBZ drug-drug cocrystal hydrate, which can be considered as an alternative CBZ solid form for oral usage, possessing additive pharmacological effect.
- 21 May 2025
- Published by MDPI AG in Pharmaceutics
- Vol. 17 (5) , 678
Open AccessNovel Drug–Drug Cocrystalline Forms of Carbamazepine with Sulfacetamide: Preparation, Characterization, and In Vitro/In Vivo Performance Evaluation
Objectives: Drug–drug cocrystallization represents a promising approach for the development of novel combination drugs with improved physicochemical and biopharmaceutical properties. The aim of the present research is to prepare novel drug-drug cocrystalline forms of antiepileptic drug carbamazepine (CBZ) with sulfacetamide (SCTM). Methods: The novel CBZ cocrystal methanol solvate and cocrystal hydrate were prepared via solvent evaporation technique and characterized by single crystal X-ray diffraction, differential scanning calorimetry and thermogravimetric analysis. Results: Single-crystal X-ray diffraction and thermal analysis revealed that the multicomponent solids are isostructural, wherein the solvent molecule does not play a structure-forming role. To optimize the synthesis of [CBZ+SCTM+H2O] (1:1:0.7), the binary and ternary phase diagrams were constructed in acetonitrile at 25 °C. A thorough investigation of the cocrystal hydrate behavior in aqueous solution showed that the pH of the dissolution medium exerted a significant effect on the stability and solubility of [CBZ+SCTM+H2O] (1:1:0.7). According to the dissolution and diffusion experiments in a buffer solution pH 6.5, the cocrystal hydrate characterized an enhanced dissolution rate and flux of CBZ. Pharmacokinetic studies in rabbits showed that the novel cocrystal hydrate exhibited a comparable bioavailability to the parent CBZ. Conclusions: Overall, this work reports the preparation of a novel CBZ drug-drug cocrystal hydrate, which can be considered as an alternative CBZ solid form for oral usage, possessing additive pharmacological effect.
- Open Access
A Combination of Virtual and Experimental Screening Tools for the Prediction of Nitrofurantoin Multicomponent Crystals with Pyridine Derivatives
Thirty-four binary systems of nitrofurantoin with pyridine derivatives were analyzed by combining virtual (molecular complementarity prediction and hydrogen bond propensity calculations) and experimental (liquid-assisted grinding) screening methods. A new modification of the hydrogen bond propensity calculation method (the integrated hydrogen bond propensity calculation method) with significantly improved virtual screening efficiency was proposed. Novel cocrystals of nitrofurantoin with 3-aminopyridine and 2-(1H-Imidazol-2-yl)pyridine were discovered. The crystal structures of the new cocrystals were determined from single-crystal X-ray diffraction data, and the hydrogen bond patterns were studied in conjunction with the Molecular Electrostatic Potential maps of the components. The nitrofurantoin cocrystal with 3-aminopyridine was found to exist in two polymorphic modifications. The origins of the different stability of the polymorphic forms were rationalized both in terms of total lattice enthalpy and free energy derived from periodic DFT-D3 calculations and in terms of the non-covalent interaction energy distribution in crystal.
Open AccessA Combination of Virtual and Experimental Screening Tools for the Prediction of Nitrofurantoin Multicomponent Crystals with Pyridine Derivatives
Thirty-four binary systems of nitrofurantoin with pyridine derivatives were analyzed by combining virtual (molecular complementarity prediction and hydrogen bond propensity calculations) and experimental (liquid-assisted grinding) screening methods. A new modification of the hydrogen bond propensity calculation method (the integrated hydrogen bond propensity calculation method) with significantly improved virtual screening efficiency was proposed. Novel cocrystals of nitrofurantoin with 3-aminopyridine and 2-(1H-Imidazol-2-yl)pyridine were discovered. The crystal structures of the new cocrystals were determined from single-crystal X-ray diffraction data, and the hydrogen bond patterns were studied in conjunction with the Molecular Electrostatic Potential maps of the components. The nitrofurantoin cocrystal with 3-aminopyridine was found to exist in two polymorphic modifications. The origins of the different stability of the polymorphic forms were rationalized both in terms of total lattice enthalpy and free energy derived from periodic DFT-D3 calculations and in terms of the non-covalent interaction energy distribution in crystal.
- Open Access
New Solid Forms of Nitrofurantoin and 4-Aminopyridine Salt: Influence of Salt Hydration Level on Crystal Packing and Physicochemical Properties
The crystallization of the poorly soluble drug nitrofurantoin (NFT) with 4-aminopyridine (4AmPy) resulted in three multicomponent solid forms with different hydration levels: anhydrous salt [NFT+4AmPy] (1:1), salt monohydrate [NFT+4AmPy+H2O] (1:1:1), and salt tetrahydrate [NFT+4AmPy+H2O] (1:1:4). Each salt was selectively prepared by liquid-assisted grinding in the presence of acetonitrile or ethanol/water mixture at a specific composition. The NFT hydrated salts were characterized using single crystal X-ray diffraction. The [NFT+4AmPy+H2O] salt (1:1:1) crystallized as an isolated site hydrate, while the [NFT+4AmPy+H2O] salt (1:1:4) crystallized as a channel hydrate. The dehydration processes of the NFT salt hydrates were investigated using differential scanning calorimetry and thermogravimetric analysis. A powder dissolution experiment was carried out for all NFT multicomponent solid forms in pH 7.4 phosphate buffer solution at 37 °C.
Open AccessNew Solid Forms of Nitrofurantoin and 4-Aminopyridine Salt: Influence of Salt Hydration Level on Crystal Packing and Physicochemical Properties
The crystallization of the poorly soluble drug nitrofurantoin (NFT) with 4-aminopyridine (4AmPy) resulted in three multicomponent solid forms with different hydration levels: anhydrous salt [NFT+4AmPy] (1:1), salt monohydrate [NFT+4AmPy+H2O] (1:1:1), and salt tetrahydrate [NFT+4AmPy+H2O] (1:1:4). Each salt was selectively prepared by liquid-assisted grinding in the presence of acetonitrile or ethanol/water mixture at a specific composition. The NFT hydrated salts were characterized using single crystal X-ray diffraction. The [NFT+4AmPy+H2O] salt (1:1:1) crystallized as an isolated site hydrate, while the [NFT+4AmPy+H2O] salt (1:1:4) crystallized as a channel hydrate. The dehydration processes of the NFT salt hydrates were investigated using differential scanning calorimetry and thermogravimetric analysis. A powder dissolution experiment was carried out for all NFT multicomponent solid forms in pH 7.4 phosphate buffer solution at 37 °C.
- Open Access
- 6 September 2022
- Published by MDPI AG in Pharmaceutics
- Vol. 14 (9) , 1881
Formation Thermodynamics of Carbamazepine with Benzamide, Para-Hydroxybenzamide and Isonicotinamide Cocrystals: Experimental and Theoretical Study
Formation thermodynamic parameters for three cocrystals of carbamazepine (CBZ) with structurally related coformers (benzamide (BZA), para-hydroxybenzamide (4-OH-BZA) and isonicotinamide (INAM)) were determined by experimental (cocrystal solubility and competitive reaction methods) and computational techniques. The experimental solubility values of cocrystal components at eutectic points and solubility product of cocrystals [CBZ + BZA], [CBZ + 4-OH-BZA], and [CBZ + INAM] in acetonitrile at 293.15 K, 298.15 K, 303.15 K, 308.15 K, and 313.15 K were measured. All the thermodynamic functions (Gibbs free energy, enthalpy, and entropy) of cocrystals formation were evaluated from the experimental data. The crystal structure of [CBZ + BZA] (1:1) cocrystal was solved and analyzed by the single crystal X-ray diffractometry. A correlation between the solubility products and pure coformers solubility values has been found for CBZ cocrystals. The relationship between the entropy term and the molecular volume of the cocrystal formation has been revealed. The effectiveness of the estimation of the cocrystal formation thermodynamic parameters, based on the knowledge of the melting temperatures of active pharmaceutical ingredients, coformers, cocrystals, as well as the sublimation Gibbs energies and enthalpies of the individual components, was proven. A new method for the comparative assessment of the cocrystal stability based on the H-bond propensity analysis was proposed. The experimental and theoretical results on the thermodynamic parameters of the cocrystal formation were shown to be in good agreement. According to the thermodynamic stability, the studied cocrystals can be arranged in the following order: [CBZ + 4-OH-BZA] > [CBZ + BZA] > [CBZ + INAM].
- 6 September 2022
- Published by MDPI AG in Pharmaceutics
- Vol. 14 (9) , 1881
Open AccessFormation Thermodynamics of Carbamazepine with Benzamide, Para-Hydroxybenzamide and Isonicotinamide Cocrystals: Experimental and Theoretical Study
Formation thermodynamic parameters for three cocrystals of carbamazepine (CBZ) with structurally related coformers (benzamide (BZA), para-hydroxybenzamide (4-OH-BZA) and isonicotinamide (INAM)) were determined by experimental (cocrystal solubility and competitive reaction methods) and computational techniques. The experimental solubility values of cocrystal components at eutectic points and solubility product of cocrystals [CBZ + BZA], [CBZ + 4-OH-BZA], and [CBZ + INAM] in acetonitrile at 293.15 K, 298.15 K, 303.15 K, 308.15 K, and 313.15 K were measured. All the thermodynamic functions (Gibbs free energy, enthalpy, and entropy) of cocrystals formation were evaluated from the experimental data. The crystal structure of [CBZ + BZA] (1:1) cocrystal was solved and analyzed by the single crystal X-ray diffractometry. A correlation between the solubility products and pure coformers solubility values has been found for CBZ cocrystals. The relationship between the entropy term and the molecular volume of the cocrystal formation has been revealed. The effectiveness of the estimation of the cocrystal formation thermodynamic parameters, based on the knowledge of the melting temperatures of active pharmaceutical ingredients, coformers, cocrystals, as well as the sublimation Gibbs energies and enthalpies of the individual components, was proven. A new method for the comparative assessment of the cocrystal stability based on the H-bond propensity analysis was proposed. The experimental and theoretical results on the thermodynamic parameters of the cocrystal formation were shown to be in good agreement. According to the thermodynamic stability, the studied cocrystals can be arranged in the following order: [CBZ + 4-OH-BZA] > [CBZ + BZA] > [CBZ + INAM].
- Open Access
- 22 May 2022
- Published by MDPI AG in Pharmaceutics
- Vol. 14 (5) , 1107
Simultaneous Improvement of Dissolution Behavior and Oral Bioavailability of Antifungal Miconazole via Cocrystal and Salt Formation
Miconazole shows low oral bioavailability in humans due to poor aqueous solubility, although it has demonstrated various pharmacological activities such as antifungal, anti-tubercular and anti-tumor effects. Cocrystal/salt formation is one of the effective methods for solving this problem. In this study, different methods (liquid-assisted grinding, slurrying and lyophilization) were used to investigate their impact on the formation of the miconazole multicomponent crystals with succinic, maleic and dl-tartaric acids. The solid state of the prepared powder was characterized by differential scanning calorimetry, powder X-ray diffraction and scanning electron microscopy. It was found that lyophilization not only promotes partial amorphization of both salts but also allows obtaining a new polymorph of the miconazole salt with dl-tartaric acid. The lyophilized salts compared with the same samples prepared by two other methods showed better dissolution rates but low stability during the studies due to rapid recrystallization. Overall, it was determined that the preparation method of multicomponent crystals affects the solid-state characteristics and miconazole physicochemical properties significantly. The in vivo studies revealed that the miconazole multicomponent crystals indicated the higher peak blood concentration and area under the curve from 0 to 32 h values 2.4-, 2.9- and 4.6-fold higher than the pure drug. Therefore, this study demonstrated that multicomponent crystals are promising formulations for enhancing the oral bioavailability of poorly soluble compounds.
- 22 May 2022
- Published by MDPI AG in Pharmaceutics
- Vol. 14 (5) , 1107
Open AccessSimultaneous Improvement of Dissolution Behavior and Oral Bioavailability of Antifungal Miconazole via Cocrystal and Salt Formation
Miconazole shows low oral bioavailability in humans due to poor aqueous solubility, although it has demonstrated various pharmacological activities such as antifungal, anti-tubercular and anti-tumor effects. Cocrystal/salt formation is one of the effective methods for solving this problem. In this study, different methods (liquid-assisted grinding, slurrying and lyophilization) were used to investigate their impact on the formation of the miconazole multicomponent crystals with succinic, maleic and dl-tartaric acids. The solid state of the prepared powder was characterized by differential scanning calorimetry, powder X-ray diffraction and scanning electron microscopy. It was found that lyophilization not only promotes partial amorphization of both salts but also allows obtaining a new polymorph of the miconazole salt with dl-tartaric acid. The lyophilized salts compared with the same samples prepared by two other methods showed better dissolution rates but low stability during the studies due to rapid recrystallization. Overall, it was determined that the preparation method of multicomponent crystals affects the solid-state characteristics and miconazole physicochemical properties significantly. The in vivo studies revealed that the miconazole multicomponent crystals indicated the higher peak blood concentration and area under the curve from 0 to 32 h values 2.4-, 2.9- and 4.6-fold higher than the pure drug. Therefore, this study demonstrated that multicomponent crystals are promising formulations for enhancing the oral bioavailability of poorly soluble compounds.